ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended March 31, 2014...
Health Care Stocks on our Radar -- Research on Abbott Laboratories, Medtronic, Hologic, and ArthroCare Editor Note: For more information about this release, please scroll to bottom PR...
Appointments, Stock Price Updates, Acquisitions, Financial Results and Technology Deployments - Analyst Notes on Stryker, ArthroCare, Novavax, Cooper, and Varian Editor Note: For more information...
Pre-Market Health Care Stocks Analysis: Medtronic, Abbott Laboratories, Hologic, and ArthroCare Editor Note: For more information about this release, please scroll to bottom. PR Newswire LONDON...
Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare Editor Note: For more information about this release, please scroll...
ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended and year ended...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of ArthroCare Corporation (“ArthroCare” or the “Company”) (Nasdaq:...
INVESTOR ALERT - ARTHROCARE CORPORATION: The Law Offices of Vincent Wong Investigates the Sale of ARTHROCARE CORPORATION to Smith & Nephew plc -- ARTC PR Newswire NEW YORK, Feb. 11, 2014 NEW...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of ArthroCare Corporation (“ArthroCare” or the “Company”) (NASDAQ:ARTC...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of ArthroCare Corporation (“ArthroCare” or the “Company”) (Nasdaq:...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約